- Home
- MTR vs POAI Comparison
MTR vs POAI Comparison
Compare MTR & POAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTR
- POAI
- Stock Information
- Founded
- MTR 1979
- POAI 2002
- Country
- MTR United States
- POAI United States
- Employees
- MTR N/A
- POAI N/A
- Industry
- MTR Oil & Gas Production
- POAI Industrial Specialties
- Sector
- MTR Energy
- POAI Health Care
- Exchange
- MTR Nasdaq
- POAI Nasdaq
- Market Cap
- MTR 9.4M
- POAI 8.9M
- IPO Year
- MTR N/A
- POAI N/A
- Fundamental
- Price
- MTR $5.56
- POAI $0.79
- Analyst Decision
- MTR
- POAI Hold
- Analyst Count
- MTR 0
- POAI 1
- Target Price
- MTR N/A
- POAI N/A
- AVG Volume (30 Days)
- MTR 167.7K
- POAI 160.4K
- Earning Date
- MTR 01-01-0001
- POAI 08-12-2025
- Dividend Yield
- MTR 3.79%
- POAI N/A
- EPS Growth
- MTR N/A
- POAI N/A
- EPS
- MTR 0.23
- POAI N/A
- Revenue
- MTR $668,826.00
- POAI $1,729,269.00
- Revenue This Year
- MTR N/A
- POAI $486.27
- Revenue Next Year
- MTR N/A
- POAI $65.50
- P/E Ratio
- MTR $24.60
- POAI N/A
- Revenue Growth
- MTR N/A
- POAI 24.17
- 52 Week Low
- MTR $4.70
- POAI $0.55
- 52 Week High
- MTR $10.42
- POAI $3.06
- Technical
- Relative Strength Index (RSI)
- MTR 48.87
- POAI 33.09
- Support Level
- MTR $5.48
- POAI $0.79
- Resistance Level
- MTR $5.73
- POAI $0.85
- Average True Range (ATR)
- MTR 0.23
- POAI 0.05
- MACD
- MTR -0.03
- POAI -0.00
- Stochastic Oscillator
- MTR 52.38
- POAI 32.87
About MTR Mesa Royalty Trust
Mesa Royalty Trust holds net overriding royalty interests in various oil and gas properties located in the: Hugoton field of Kansas, San Juan Basin field of New Mexico, and San Juan Basin Field of Colorado.
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.